U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285317) titled 'Safety and Tolerability Evaluationof Phascolarcobacterium Faecium' on Nov. 14.
Brief Summary: The goal of this interventional study is to assess the safety and tolerability of the daily administratrion of bacterium Phascolarctobacterium faecium in healthy adults with normal weight, and in individuals with overweight and alterations in glucose metabolism. The main questions this study aims to answer are:
Is the bacterium intake safe? Is the bacterium intake well tolerated? The objecitves are to assess if the intake of the bacterium is well tolerated by assessing gastrointenstinal symptoms, and safe, by assessing biochemical markers,...